Eli Lilly's 'diabesity' medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap, Morgan Stanley …
Eli Lilly's 'diabesity' medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap, Morgan Stanley …